Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | MMP3 | P08254 | 1/20 | 0.48 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 2/20 | 0.42 |
| ▸ | CA2 | P00918 | 2/20 | 0.42 |
| ▸ | MGLL | Q99685 | 1/20 | 0.42 |
| ▸ | KIF11 | P52732 | 1/20 | 0.42 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.40 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.39 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27531830 | 1.00 | ALDH1A1 (0.56) | ALDH1A1TAAR1CYP1A2MAPK1CYP3A4 | |
| SCHEMBL27686621 | 1.00 | ALDH1A1 (0.56) | ALDH1A1TAAR1CYP1A2MAPK1CYP3A4 | |
| SCHEMBL27696029 | 1.00 | ALDH1A1 (0.56) | ALDH1A1TAAR1CYP1A2MAPK1CYP3A4 | |
| SCHEMBL27354214 | 1.00 | ALDH1A1 (0.56) | ALDH1A1TAAR1CYP1A2MAPK1CYP3A4 | |
| SCHEMBL25683 | 1.00 | ALDH1A1 (0.56) | ALDH1A1TAAR1CYP1A2MAPK1CYP3A4 | |
| SCHEMBL27623254 | 1.00 | ALDH1A1 (0.56) | ALDH1A1TAAR1CYP1A2MAPK1CYP3A4 | |
| SCHEMBL27623248 | 1.00 | ALDH1A1 (0.56) | ALDH1A1TAAR1CYP1A2MAPK1CYP3A4 | |
| SCHEMBL9334552 | 1.00 | ALDH1A1 (0.56) | ALDH1A1TAAR1CYP1A2MAPK1CYP3A4 | |
| SCHEMBL27686618 | 1.00 | ALDH1A1 (0.56) | ALDH1A1TAAR1CYP1A2MAPK1CYP3A4 | |
| SCHEMBL27623253 | 1.00 | ALDH1A1 (0.56) | ALDH1A1TAAR1CYP1A2MAPK1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020241503-A1 | RESIN COMPOSITION AND MOLDED ARTICLE THEREOF | 株式会社ADEKA | 2020-12-03 | — | — | WO | disclosed |
| EP-1640430-B1 | Luminescent material and organic electroluminescent device using the same | JNC CORP (JP) | 2011-09-21 | — | — | EP | disclosed |
| EP-2177586-A1 | Luminescent material and organic electroluminescent device using the same | CHISSO CORPORATION (JP) | 2010-04-21 | — | — | EP | disclosed |
| CN-100340559-C | Nitrogen containing heterobicycles as factor XA inhibitors | DU PONT PHARM CO (US) | 2007-10-03 | — | — | CN | disclosed |
| EP-1640430-A1 | Luminescent material and organic electroluminescent device using the same | CHISSO CORPORATION (JP) | 2006-03-29 | — | — | EP | disclosed |
| US-20060014046-A1 | Luminescent material and organic electroluminescent device using the same | CHISSO CORPORATION (JP) | 2006-01-19 | — | — | US | disclosed |
| EP-0988037-A1 | PORPHYRIN COMPOUNDS AS TELOMERASE INHIBITORS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2000-03-29 | — | — | EP | disclosed |
| WO-1998033503-A1 | PORPHYRIN COMPOUNDS AS TELOMERASE INHIBITORS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1998-08-06 | — | — | WO | disclosed |
| US-5235061-A | 2,4-disilaalkanes; agriculture | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 1993-08-10 | — | — | US | disclosed |
| US-4536400-A | VIRICIDES | ASTRA LAKEMEDEL AKTIEBOLAG (SE) | 1985-08-20 | — | — | US | disclosed |
| US-4525202-A | Phosphonium salts of N-phosphonomethylglycine and their use as herbicides and plant growth regulants | STAUFFER CHEMICAL CO. (US) | 1985-06-25 | — | — | US | disclosed |
| US-4438020-A | CARBONYLATION, HYDROGENATION | GULF RESEARCH & DEVELOPMENT COMPANY (US) | 1984-03-20 | — | — | US | disclosed |
| US-4361706-A | FROM METHANOL, HYDROGEN AND CARBON MONOXIDE IN PRESENCE OF COBALT,IODINE AND PHOSPHORUS COMPOUND | GULF RESEARCH & DEVELOPMENT COMPANY (US) | 1982-11-30 | — | — | US | disclosed |
| US-4352947-A | METHANOL; CARBON MONOXIDE; HYDROGEN; COBALT; IODINE; RUTHENIUM; AND PHOSPHORUS, NITROGEN, OR ARSENIC LIGAND | GULF RESEARCH & DEVELOPMENT COMPANY (US) | 1982-10-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060014046-A1 | Luminescent material and organic electroluminescent device using the same | C1S, EPB41, EPB41L2 | ALDH1A1 1227/4885TAAR1 683/4885CYP1A2 829/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.